🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to find the number of natural killer (NK) cell...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2018-05-22
Trial ID
NCT02890758
Treatments Being Tested
This research study is evaluating the safety and efficacy of a combination ...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2020-07-20
Trial ID
NCT04290546
Treatments Being Tested
This is a single center, open-label, pharmacokinetic study of ALT-803 admin...
Status
Completed
Location
Quotient Sciences
Start Date
2017-12-27
Trial ID
NCT03381586
Treatments Being Tested
Background: Immunotherapy is a powerful tool in the fight against cancer. ...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2021-12-14
Trial ID
NCT04847466
Treatments Being Tested
This phase Ib trial will investigate the effect of N-803 in combination wit...
Status
Withdrawn
Location
Multiple Locations
Start Date
2026-02-15
Trial ID
NCT07217496
To assess the safety of combination immune therapy in HIV-infected particip...
Status
Withdrawn
Location
University of California
Start Date
2020-01-01
Trial ID
NCT04144335
Treatments Being Tested
This is a randomized open-label phase 2 study to evaluate the efficacy and ...
Status
Withdrawn
Location
Chan Soon-Shiong Institute for Medicine
Start Date
2018-09
Trial ID
NCT03554109
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-12
Trial ID
NCT03167164
Background: Immunotherapy drugs help the body to fight cancer. Scientists ...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2018-05-01
Trial ID
NCT03493945
Reducing HIV persistence in lymph nodes by Interleukin-15 (IL-15) Receptor ...
Status
Active Not Recruiting
Location
Thai Red Cross AIDS Research Centre
Start Date
2021-03-01
Trial ID
NCT04505501
Treatments Being Tested